Our study suggested that Baicalein showed HDAC‐1/8 inhibition effects and exerted outstanding anti‐leukemia effects in CBF‐AML, while no effects on the expression of HDAC inhibitor‐associated ABC transporter genes could be observed. This evidence concerns the gene HDAC1 and acute myeloid leukemia.